Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis.

Haley M Zylberberg Sheila D Rustgi Anthony Yang Anne Aronson Elizabeth Kessel Sunil Amin Aimee L Lucas

Published in: Gut and liver (2021)

Our findings suggest that the use of bisphosphonates, whether alone or in combination with statins, does not confer a survival advantage in patients with PDAC.

Keyphrases

free survival
cardiovascular disease